Effect of milnacipran on brain‑derived neurotrophic factor and oxidative stress biomarkers in patients of major depressive disorder
Acta Neurobiologiae Experimentalis · 24.04.2023 · 83 (1) · 57-62
DOI: 10.55782/ane-2023-006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neurobiologiae Experimentalis, online erschienen am 24.04.2023. Verfasst von Rachna Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India; drrachna1@rediffmail.com. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Emerging hypotheses in the pathophysiology of major depressive disorder (MDD) suggest important role of neurotrophicfactors and oxidative stress. This study assessed the effect of milnacipran (a dual serotonin‑noradrenaline reuptake inhibitor) onbrain‑derived neurotrophic factor (BDNF) and oxidative stress biomarkers i.e., malondialdehyde (MDA), glutathione‑S‑transferase (GST) and glutathione reductase (GR) in patients of MDD. Thirty patients (aged 18 to 60 years) with MDD diagnosed by DSM‑IV criteria, with Hamilton Depression Rating scale (HAM‑D) score ≥ 14 were included in the study. Patients were given milnacipran in the doses of 50‑100 mg once daily. Patients were followed up for 12 weeks. HAM‑D score at the start of treatment was 17.8±1.7 which significantly reduced to 8.9±3.1 at 12 weeks of treatment. In responders, the plasma BDNF levels increased significantly at 12 weeks post treatment. There was no significant change in the pre‑ and post‑treatment values of oxidative stress parameters (MDA, GST and GR) after 12 week treatment. Milnacipran is effective and well tolerated in MDD patients, and its therapeutic response is associated with an increase in plasma BDNF levels. However, milnacipran did not affect oxidative stress biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India; drrachna1@rediffmail.com.
- Department of Pharmacology, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India.
- Department of Psychiatry, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India.
- Department of Biochemistry, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India.
- Department of Pharmacology, Lady Hardinge Medical College and Smt. S.K. Hospital, New Delhi, India.
Zitieren
APA
Gupta, R., Ghosh, R., Bhatia, M. S., Tripathi, A. K., & Gupta, L. K. (2023). Effect of milnacipran on brain‑derived neurotrophic factor and oxidative stress biomarkers in patients of major depressive disorder. Acta Neurobiologiae Experimentalis, 83(1), 57-62. https://doi.org/10.55782/ane-2023-006
Vancouver
Gupta R, Ghosh R, Bhatia MS, Tripathi AK, Gupta LK. Effect of milnacipran on brain‑derived neurotrophic factor and oxidative stress biomarkers in patients of major depressive disorder. Acta Neurobiologiae Experimentalis. 2023;83(1):57-62. doi:10.55782/ane-2023-006
BibTeX
@article{Gupta2023,
author = {Gupta, Rachna and Ghosh, Rupanwita and Bhatia, Manjeet S and Tripathi, A K and Gupta, Lalit K},
title = {Effect of milnacipran on brain‑derived neurotrophic factor and oxidative stress biomarkers in patients of major depressive disorder},
journal = {Acta Neurobiologiae Experimentalis},
year = {2023},
volume = {83},
number = {1},
pages = {57--62},
doi = {10.55782/ane-2023-006}
}
EUVIMED